Abstract-The search for and development of radiation countermeasures to treat acute lethal radiation injury has been underway for the past six decades, resulting in the identification of multiple classes of radiation countermeasures. However, to date only granulocyte colony-stimulating factor (Neupogen) and PEGylated granulocyte colony-stimulating factor (Neulasta) have been approved by the U.S. Food and Drug Administration for the treatment of hematopoietic acute radiation syndrome. Gammatocotrienol has demonstrated radioprotective efficacy in murine and nonhuman primate models. Currently, this agent is under advanced development as a radioprotector, and the authors are trying to identify its efficacy biomarkers. In this study, global metabolomic changes were analyzed using ultraperformance liquid chromatography quadrupole time-of-flight mass spectrometry. The pilot study using 16 nonhuman primates (8 nonhuman primates each in gamma-tocotrienol-and vehicle-treated groups), with samples obtained from gamma-tocotrienol-treated and irradiated nonhuman primates, demonstrates several metabolites that are altered after irradiation, including compounds involved in fatty acid beta-oxidation, purine catabolism, and amino acid metabolism. The machine-learning algorithm, Random Forest, separated control, irradiated gamma-tocotrienol-treated, and irradiated vehicle-treated nonhuman primates at 12 h and 24 h as evident in a multidimensional scaling plot. Primary metabolites validated included carnitine/acylcarnitines, amino acids, creatine, and xanthine. Overall, gamma-tocotrienol administration reduced high fluctuations in serum metabolite levels, suggesting an overall beneficial effect on animals exposed to radiation. This initial assessment also highlights the utility of metabolomics in determining underlying physiological mechanisms responsible for the radioprotective efficacy of gamma-tocotrienol. Health Phys. 115(1):3-11; 2018
INTRODUCTION
THE THREAT of a nuclear or radiological disaster is a serious concern and a top priority for all U.S. agencies involved in domestic security and public health preparedness, as well as for the military. As made evident by the BioShield legislation, the need for new countermeasures that are safe, easily administered, and effective at reducing or eliminating the public health impact of acute high-dose radiation are urgently needed (Singh et al. 2016c ). In the event of radiological or nuclear event exposure, medical care would be needed to treat exposure victims developing acute radiation syndrome (ARS) (DiCarlo et al. 2011; Hall and Giaccia 2012) .
Acute radiation injury occurs at whole-body doses above 2 Gy, with symptoms growing in severity as the level of radiation exposure increases (Hall and Giaccia 2012) . A dose range of 2-6 Gy is characterized by the loss of hematopoietic cell regenerative ability, resulting in hematopoietic-ARS (H-ARS). In the exposure range of 6-10 Gy, hematopoietic symptoms are present in addition to symptoms caused by significant breakdown of the gastrointestinal (GI) system, resulting in GI-ARS. H-ARS and GI-ARS are recognized as the major subsyndromes of ARS that can be treated with radiation countermeasures. The search for radiation countermeasures to lethal radiation injury has been underway for the past several decades, resulting in the identification of multiple classes of radiation countermeasures Drouet and Herodin 2014; Herodin and Drouet 2005; Seed 2005; Singh et al. 2012 Singh et al. , 2014 Weiss and Landauer 2009) . However, to date only two radiomitigators for H-ARS have been approved for use by the 1 U.S. Food and Drug Administration (FDA) for the mitigation of H-ARS (Farese et al. 2013; Farese and MacVittie 2015; Global Biodefense 2015; Hankey et al. 2015) . There is no radioprotector approved by the U.S. FDA that can be used prior to radiation exposure. Further, there is no radioprotector or radiomitigator approved by U.S. FDA for GI-ARS.
Vitamin E is well known for its antioxidant, antiinflammatory, and neuroprotective properties (Sen et al. 2006; Singh et al. 2013) . Vitamin E represents a family of compounds, acting as antioxidants, that control free-radical production and regulate peroxidation reactions within the body (Singh et al. 2016a ). The vitamin E family has eight different isoforms that belong to two groups: four saturated analogs (alpha, beta, gamma, and delta) known as tocopherols and four unsaturated analogs called tocotrienols. These eight agents are collectively referred to as tocols. Gammatocotrienol (GT3) is a potent inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase. Its antioxidant activity is an important reason for evaluating its radioprotective efficacy. During the last 10 years, it has received significant attention and appears to be one of the most encouraging radiation countermeasures among tocols tested to date (Singh et al. 2016a) . Further, studies suggest that GT3-stimulated granulocyte colony-stimulating factor (G-CSF) is involved in its radioprotective mechanism, at least in the murine model (Kulkarni et al. 2013) . Lately, GT3 has been tested as a radioprotector in a pilot study in the nonhuman primate (NHP) model and has demonstrated efficacy for improving ionizing-radiation-induced cytopenia, neutropenia, and thrombocytopenia in the absence of any supportive care (Singh et al. 2016b ). GT3 has also been studied for modulating microRNA in murine and NHP models with the objective of identifying its efficacy biomarker (Fendler et al. 2017; Ghosh et al. 2016) .
Here, the authors report ionizing-radiation-induced metabolic changes in serum samples of GT3 or vehicletreated NHPs using a global metabolomics approach with an ultraperformance liquid chromatography (UPLC) quadrupole time-of-flight mass spectrometry (QTOF-MS) platform at 12 h and 24 h after 6.5 Gy total-body irradiation. This research found lower fluctuations of most metabolites in the GT3-treated group, suggesting a beneficial response to the radioprotective efficacy of GT3. Furthermore, this pilot study demonstrates the utility of metabolomics in deciphering the physiological effects of GT3 as a radioprotector.
MATERIALS AND METHODS

Animals and animal care
Sixteen naïve rhesus macaques (Macaca mulatta, Chinese substrain), eight males and eight females, 49-68 mo of age, weighing 3.8-6.6 kg, were obtained from Primate Products, Inc. (7780 Executive Center Dr., Miami, FL 33166 USA) and quarantined for six weeks prior to initiation of the experiment. Animal quarantine, housing, health monitoring, care, and enrichment during the experimental period have been previously described (Singh et al. 2016b ). Animals were stratified by sex and body-weight increases during the quarantine period and then assigned to GT3-treated and vehicle groups. Due to study-specific reasons, paired housing was not possible during the experiment. The animals were housed individually, but they were able to see and touch conspecifics through the cage divider. This also eliminated the chance of conflict injuries that could have been caused by pair housing. Animals that are irradiated are more prone to infection as their natural immunity is suppressed. This animal study was conducted in a facility accredited by the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) International. All procedures involving animals were approved by the Institutional Animal Care and Use Committee (IACUC) and Department of Defense Animal Care and Use Review Office (ACURO). This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health (National Research Council of the National Academy of Sciences 2011).
Drug preparation and administration
Pyrogen-free samples of GT3 olive oil formulations (50 mg mL , adjusted precisely to the body weight of individual NHPs. A single administration of the above dose of GT3 without any supportive care was equivalent, in terms of improving hematopoietic recovery, to multiple doses of Neupogen and two doses of Neulasta with full supportive care (including blood products) in the NHP model. Drug or vehicle was administered to eight animals each (four males and four females) at the dorsal scapular area (between the shoulder blades) 24 h prior to irradiation as described in detail earlier (Singh et al. 2016b ).
Radiation exposure
Food was withheld from each animal approximately 12-18 h prior to radiation exposure to minimize the occurrence of radiation-induced vomiting. Approximately 30-45 min prior to irradiation, NHPs were administered 10-15 mg kg −1 of ketamine hydrochloride intramuscularly for sedation, then placed in custom-made Plexiglas irradiation boxes and secured in a seated position. Two NHPs were placed on the irradiation platform facing away from each other and exposed with a midline dose of 6.5 Gy [lethal dose to 25-50% of the population within 60 d (LD 25-50/60 ) without supportive care] 60 Co-gamma radiation at a dose rate of 0.6 Gy min −1 from both sides (bilateral, simultaneous exposure). To deliver the precise dose, NHPs' abdominal widths were measured with digital calipers. Animals were observed throughout the irradiation procedure via in-room cameras. Following irradiation, animals were returned to the transport cart and to their cages in the housing area and monitored for recovery from the procedure. Dose-rate measurements were based primarily on the alanine/electron paramagnetic resonance (EPR) system as described earlier (Singh et al. 2016b ).
Serum sample collection
Blood was collected by venipuncture from the saphenous vein on the caudal aspect of the lower leg, placed in serum-separating tubes, allowed to clot for 30 min, and centrifuged (10 min, 400 Â g). Serum samples were stored at −70°C until use.
Chemicals
All reagents were LC-MS grade (Fisher Scientific, 4500 Turnberry Dr., Hanover Park, IL 60133 USA) and chemicals [tryptophan, leucine, isoleucine, L-carnitine, creatine, xanthine, methionine, proline, and propionylcarnitine (Sigma-Aldrich, 3050 Spruce St., St. Louis, MO 63103 USA) were of the highest purity available.
Sample preparation and analysis
Serum ( Data processing, statistical analysis, and marker validation Deconvolution and peak alignment on the total ion chromatogram (TIC) were performed using Progenesis QI (Nonlinear Dynamics, Keel House, Garth Heads, Newcastle Upon Tyne NE1 2JE, UK). Preprocessed data was initially analyzed with the in-house statistical package MetaboLyzer ) for univariate analysis as previously described (Pannkuk et al. 2016b ). Putative ion pathways were determined by comparing to the Kyoto encyclopedia of genes and genomes (KEGG) (Kanehisa and Goto 2000) . Complete presence ions (≥ 70%) were analyzed with a standard singular value decomposition-based principal component analysis (PCA) using in-house software, and a multidimensional scaling (MDS) plot and heat map were ) heat map generated by Random Forest analysis comparing metabolomic signatures (ESI + ) of serum biomarkers from NHPs exposed to 6.5 Gy gamma radiation after 12 and 24 h. One group was administered GT3 as a radioprotector 24 h prior to irradiation. Higher separation was seen between GT3 and control groups along dimension 1 while the non-GT3 group separated the greatest from the control along dimension 2 at 12 h. generated with Random Forest (RF) using R version 2.15.2. A subset of statistically significant ions were identified [identification: human metabolome database (HMDB); significance: Welch's t-test (p < 0.05)] and were chosen for validation against pure standards (diluted in 1:1 ACN: H 2 O) using tandem MS and the METLIN tandem MS database. Validated and normalized ions were checked for normality with a Shapiro-Wilk test, homogenous variances with a Levene's test, sphericity using Geisser-Greenhouse epsilon value, significance (p < 0.05) with a repeated measures analysis of variance (ANOVA), and graphed using GraphPad Prism 6 (GraphPad Software, Inc., 7825 Fay Av., #230, La Jolla, CA 92037 USA; SAS version 9.4, SAS Institute Inc., 100 SAS Campus Dr., Cary, NC 27513 USA).
RESULTS
Biomarker identification and validation
The 12-and 24-h postirradiation time points clearly separated from the untreated control samples for both vehicle and GT3-treated groups when compared with an unsupervised PCA ( Supplementary Fig. S1 , http://links.lww. com/HP/A123). The top 250 ions in ESI + mode had an accuracy of 89.4%, and the top 137 ions in ESI − mode had an accuracy of 66% (Fig. 1) . Multivariate data analysis of the proximity matrix from the machine-learning RF algorithm indicated all NHP groups exposed to 60 Co-gamma radiation separated from the unirradiated control group, with the GT3-treated group separating the most on dimension 1 and the vehicle-treated group separating more on dimension 2 (Fig. 1) . Manual inspection of the heat map generated by RF indicated that some variation may be due to putative steroids present in the 12-h vehicle group and putative sphingomyelin, phosphatidylserine, and gangliosides in the GT3 group.
Metabolomics data analysis requires validation of putative metabolites identified by matching the retention time (RT) and MS/MS fragmentation of compounds in the samples to a pure standard using the same analytical platform (putative ions listed in Supplementary Table 1 ). Univariate data analysis by repeated measures ANOVA was used to compare validated ions at 12 and 24 h for NHPs receiving either a vehicle or GT3 as a radioprotector 24 h prior to irradiation. In animals not administered GT3, xanthine (p = 0.034), and creatine (p = 0.053) increased at 12 h; xanthine returned closer to preirradiation levels at 24 h, and creatine levels were slightly lower than levels at 12 h (Fig. 2) . Levels did not change significantly in animals receiving GT3 [xanthine (p = 0.178) and creatine (p = 0.368)], although a similar trend was observed. Carnitine and propionylcarnitine showed slight decreases at 12 h in the vehicle group [carnitine (p < 0.001), propionylcarnitine (p = 0.008)], while levels in the GT3-treated group did not significantly change [carnitine (p = 0.174), propionylcarnitine (p = 0.127)]. Minor changes were observed in levels of one nonessential amino acid and three essential amino acids (Fig. 3) . Methionine significantly changed in the vehicle group (p = 0.001, F = 11.720) but not the GT3-treated group (p = 0.068, F = 3.269); however, with the difference in within-group variation, a higher sample size may be needed for this metabolite. Proline (a nonessential amino acid) decreased significantly in both groups [vehicle (p = 0.004), GT3 (p = 0.007)] and tryptophan decreased significantly only in the GT3 group (p = 0.026) and not the vehicle group (p = 0.589). Leucine/isoleucine (p = 0.048) increased at 12 h while returning closer to the preirradiation level but not to the GT3-treated group level (p = 0.562). Changes in tryptophan have been linked to the host microbiota rather than being a direct product of radiation exposure Ó Broin et al. 2015) .
DISCUSSION
GT3 is a promising radiation countermeasure being developed as a radioprotector that can be administered prior to radiation exposure for the benefit of first responders and military personnel (Singh et al. 2016a ). It has demonstrated significant radioprotective efficacy in mouse and NHP models against ionizing radiation, and its radioprotective efficacy has been shown to be mediated through G-CSF in the murine model (Kulkarni et al. 2013) . Currently, GT3 is under advanced development with support from U.S. Department of Defense with an objective of submitting an investigational new drug (IND) application to U.S. FDA. Identification of its efficacy biomarker is gaining momentum and pushing this agent toward FDA approval following the Animal Rule (U.S. Food and Drug Administration Guidance for Industry: Product Development Under the Animal Rule; USFDA 2015). Recently, GT3 has also been studied for modulating microRNA (miRNA) in murine and NHP models with an objective of identifying its efficacy biomarker (Fendler et al. 2017; Ghosh et al. 2016) . The authors have shown that three miRNAs (miR-30a, miR-126, and miR-375) correlate with the radioprotective efficacy of GT3 in NHPs; these miRNAs in GT3-treated 60 Co totalbody gamma-irradiated animals resembled the unirradiated animals (Fendler et al. 2017 ). Exposure to ionizing radiation stimulates a set of complex biological responses including gene expression and protein synthesis that ultimately leads to dysregulation of metabolic processes. Recently, there have been several reports showing metabolites as radiation biomarkers in NHP urine and serum (Pannkuk et al. 2017a and b) . In the present pilot study, the authors used a global metabolomics approach to determine metabolomic serum changes in NHPs administered radioprotective GT3 or vehicle and exposed to 6.5 Gy total-body radiation (putative ions listed in Supplementary Table S1, http://links.lww.com/HP/A124).
Xanthine is a precursor of uric acid and is a compound involved in purine catabolism, indicating DNA damage and increased oxidation, and it has been identified as a radiation exposure marker in urine in earlier studies (Johnson et al. 2012; Laiakis et al. 2014; Manna et al. 2013; Tyburski et al. 2009 ), but opposite trends between sexes have been observed (Pannkuk et al. 2015) . Since only four NHPs of each sex were used in each group, sex-based analysis was not performed in this study. While previous studies have indicated a significantly higher xanthine concentration in urine, with the greatest fold change at 24 h, the present serum signature indicates higher fold change at 12 h with lower levels at 24 h (Johnson et al. 2012; Tyburski et al. 2009 ). It is possible that higher xanthine levels are observed in serum at 12 h as a direct product of DNA damage, and xanthine is being eliminated from the body at 24 h when its concentration is higher in urine. Similarly, a slight increase in serum creatine levels was observed at 12 h for both GT3-and vehicle-treated groups; however, levels returned closer to basal levels in the GT3 group. Fig. 2 . Dose response of serum biomarkers from NHPs exposed to 6.5 Gy gamma radiation after 12 and 24 h (mean ± SEM). Graphs in the left column represent vehicle group, and graphs in the right column represent the GT3 group. The GT3 group had a lower fold change of xanthine (fold change 2.35 vs. 4.57) and creatine (fold change 1.37 vs. 1.52) 12 h postirradiation than the vehicle group. The GT3 group had lower increases in carnitine (* indicates significant value p < 0.05, **p = 0.053).
Creatine is a well-known marker of radiation exposure in NHP urine (Johnson et al. 2012; Pannkuk et al. 2015) and may indicate decreased muscle activity. As GT3 lowered xanthine and creatine concentration at both 12 and 24 h postirradiation compared to the vehicle-treated NHPs, this suggests beneficial effects in animals exposed to ionizing radiation.
Carnitines and acylcarnitines play important roles in fatty acid beta-oxidation. Perturbations to biofluid carnitine/ acylcarnitine concentrations have been implicated in many diverse diseases (Flanagan et al. 2010 ) and as consequences of radiation exposure from both internal and external sources Laiakis et al. 2012; Pannkuk et al. 2015) . Generally, fold changes of carnitine are much greater in urine than serum (Pannkuk et al. 2017b ). An estimated 95% of carnitine may be reabsorbed in the kidneys. However, exposure to radiation causes renal failure, limiting the amount reabsorbed and demonstrating higher concentration in urine. The present study demonstrates lower levels of serum carnitine and Fig. 3 . Dose response of serum biomarkers from NHPs exposed to 6.5 Gy gamma radiation after 12 and 24 h (mean ± SEM). Graphs in the left column represent vehicle group and graphs in the right column represent the GT3 group. Minor differences in amino acid concentration are observed between the two groups (* indicates significant value p < 0.05).
propionylcarnitine at 12 h in the vehicle group, with higher concentrations at 24 h. This may be due to decreased reabsorption efficiency at 12 h due to renal failure in the vehicle group compared to the GT3 group. Increases at 24 h in the vehicle-treated animals may represent increased cellular leakage of these metabolites, indicating longer-lasting deficiencies to fatty acid beta-oxidation. Carnitine and propionylcarnitine returned to basal levels in the GT3 group at 24 h. The reduced fluctuations observed in carnitine and propionylcarnitine may indicate positive effects on fatty acid metabolism by GT3 administration prior to irradiation.
Changes in NHP serum amino acid concentrations have been observed seven days postirradiation (Pannkuk et al., 2016a (Pannkuk et al., , 2016b (Pannkuk et al., , 2017b . Of the four amino acids validated, proline (the one nonessential amino acid detected) significantly decreased in both groups at 12 h and 24 h. Two essential amino acids (methionine and leucine/ isoleucine) significantly fluctuated in the vehicle group but not the GT3 group. Tryptophan significantly decreased in the GT3 group but did not change in the vehicle group. Tryptophan may be a microbial metabolite and is required for serotonin production, involved in GI inflammation, and important in tricarboxylic acid (TCA) cycle function and energy metabolism (Goudarzi et al. 2016; Lamas et al. 2016; Ó Broin et al. 2015) . Serotonin is an important GI regulatory factor, and the host microbiota can increase biosynthesis (Yano et al. 2015) . Given the effects of irradiation on GI function, the interactions of GT3 on host microbiota, serotonin synthesis from tryptophan, and GI inflammation may be interesting areas for further research.
CONCLUSION
There is growing interest in the physiological effects of tocotrienols, not only as a radioprotector but also in several disease types (Torquato et al. 2016) . Here, the authors present an initial assessment of the utility of metabolomics to determine mechanisms of GT3 radioprotective efficacy. Overall, GT3 administration reduced fluctuations of validated metabolites that may indicate positive physiological effects on DNA damage, increased muscle function, fatty acid synthesis, renal function, and amino acid metabolism. Tryptophan levels decreased in the GT3-administered group, possibly representing an important interplay between GI damage from irradiation, GT3 effects on the host microbiota, and tryptophan metabolism. Future work may incorporate more metabolomic analytical platforms and transcriptomics with current metabolomic and miRNA studies to explore the efficacy of GT3 as a radiation countermeasure. 
